Investigating the Effect of Xylitol on ompK36 Overexpression, Increased Meropenem Susceptibility, and Antibiofilm Activity in a Carbapenem‐Resistant Clinical Strain of Klebsiella pneumoniae
International Journal of Microbiology · 2026-01 · 2026 (1)
DOI: 10.1155/ijm/3754560 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Microbiology, online erschienen am 12.05.2026. Verfasst von Omid Ahlelyorof und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran, tums.ac.ir. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tehran University of Medical Sciences and Health Services.
Abstract (Originalsprache)
Carbapenem‐resistant Klebsiella pneumoniae poses a significant public health threat due to limited therapeutic options. This study investigated the potential of xylitol, a sugar alcohol, to enhance meropenem activity and combat biofilms in a clinical carbapenem‐resistant K. pneumoniae strain (Kp5) and a standard susceptible strain ( K. pneumoniae subsp. pneumoniae ATCC 13883). The synergistic activity between xylitol and meropenem in inhibiting bacterial growth was assessed using a two‐dimensional checkerboard assay. Real‐time PCR was performed to assess the effect of xylitol on the expression of the porin gene ompK36 , a key determinant of carbapenem entry and resistance in K. pneumoniae . Moreover, the microtiter plate assay was used to evaluate its antibiofilm efficacy. Results showed that xylitol exhibited a synergistic effect with meropenem, leading to a significant reduction in the meropenem minimum inhibitory concentration (MIC) in both strains. Notably, the meropenem MIC for the Kp5 strain was reduced by up to 32‐fold in the presence of xylitol. Exposure to xylitol alone induced a significant upregulation of ompK36 expression in both strains, suggesting that increased porin gene expression may enhance meropenem activity. Furthermore, xylitol demonstrated potent, concentration‐dependent antibiofilm activity, both inhibiting biofilm formation and eradicating established biofilms. This approach offers a promising strategy for repurposing a safe and readily available compound to address a critical aspect of antimicrobial resistance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran, tums.ac.ir.
- Department of Precision and Molecular Medicine, Penn State College of Medicine, Hershey, Pennsylvania, USA, pennstatehershey.org.
- Research Center for Antibiotic Stewardship and Antimicrobial Resistance, Tehran University of Medical Sciences, Tehran, Iran, tums.ac.ir.
ORCID-Profile: John Flanagan, Fereshteh Jabalameli, Maryam Siroosi
Förderung
- Tehran University of Medical Sciences and Health Services
Zitieren
APA
Ahlelyorof, O., Flanagan, J., Jabalameli, F., Beigverdi, R., & Siroosi, M. (2026). Investigating the Effect of Xylitol on ompK36 Overexpression, Increased Meropenem Susceptibility, and Antibiofilm Activity in a Carbapenem‐Resistant Clinical Strain of Klebsiella pneumoniae. International Journal of Microbiology, 2026(1). https://doi.org/10.1155/ijm/3754560
Vancouver
Ahlelyorof O, Flanagan J, Jabalameli F, Beigverdi R, Siroosi M. Investigating the Effect of Xylitol on ompK36 Overexpression, Increased Meropenem Susceptibility, and Antibiofilm Activity in a Carbapenem‐Resistant Clinical Strain of Klebsiella pneumoniae. International Journal of Microbiology. 2026;2026(1). doi:10.1155/ijm/3754560
BibTeX
@article{Ahlelyorof2026,
author = {Ahlelyorof, Omid and Flanagan, John and Jabalameli, Fereshteh and Beigverdi, Reza and Siroosi, Maryam},
title = {Investigating the Effect of Xylitol on ompK36 Overexpression, Increased Meropenem Susceptibility, and Antibiofilm Activity in a Carbapenem‐Resistant Clinical Strain of Klebsiella pneumoniae},
journal = {International Journal of Microbiology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ijm/3754560}
}
EUVIMED